论文信息 - Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes - 字舞流文

Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes

G. Dangas | P. van der Harst | V. Kunadian | A. V. Van't Hof | D. Angiolillo | J. Tanguay | J. T. ten Berg | S. James | P. Gurbel | R. Storey | D. Trenk | A. Hmissi | M. Ufer | Diana A Gorog | H. Tran | J. Frenoux | C. Bernaud | P. van der harst | A. V. Van’t Hof | A. V. van‘t Hof